Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older

ClinicalTrials.gov ID: NCT02553343

Public ClinicalTrials.gov record NCT02553343. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older

Study identification

NCT ID
NCT02553343
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi Pasteur, a Sanofi Company
Industry
Enrollment
792 participants

Conditions and interventions

Conditions

Interventions

  • High-dose quadrivalent influenza virus vaccine Biological
  • High-dose influenza virus vaccine Biological
  • High-dose trivalent inactivated influenza vaccine Biological

Biological

Eligibility (public fields only)

Age range
65 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2015
Primary completion
Apr 3, 2016
Completion
Apr 3, 2016
Last update posted
Feb 8, 2018

2015 – 2016

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Not listed Milford Connecticut 06460
Not listed Coral Gables Florida 33134
Not listed Wichita Kansas 67207
Not listed St Louis Missouri 63104
Not listed Rochester New York 14609
Not listed Warwick Rhode Island 02886
Not listed Nashville Tennessee 37212
Not listed Salt Lake City Utah 84109
Not listed West Jordan Utah 84088

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02553343, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 8, 2018 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02553343 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →